Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -110,551 | 289,000 | -166,000 | -88,000 | -178,411 |
| Other Operating Activity | 1,732,441 | 1,430,000 | 1,590,000 | 1,280,000 | 178,411 |
| Operating Cash Flow | $1,621,890 | $1,719,000 | $1,424,000 | $1,192,000 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -395,494 | -180,000 | -274,000 | 1,000 | -600,527 |
| Net Acquisitions | -880,747 | -143,000 | -1,000 | -1,000 | -44,654 |
| Purchase Of Investment | N/A | -10,000 | -3,000 | -5,000 | -25,708 |
| Sale Of Investment | N/A | 11,000 | 8,000 | 3,000 | 2,871 |
| Other Investing Activity | -1,191,552 | 73,000 | 1,246,000 | 83,000 | 222,299 |
| Investing Cash Flow | $-2,467,793 | $-249,000 | $976,000 | $81,000 | $-445,719 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -77,000 | -49,000 | -312,000 | N/A |
| Common Stock Issued | 215,638 | 37,000 | 33,000 | 34,000 | 24,170 |
| Common Stock Repurchased | -374,014 | -235,000 | -214,000 | -176,000 | -266,483 |
| Dividend Paid | -652,160 | -568,000 | -684,000 | -571,000 | -54,853 |
| Other Financing Activity | -256,819 | 122,000 | 921,000 | -107,000 | -3,312,974 |
| Financing Cash Flow | $-1,067,355 | $-721,000 | $7,000 | $-1,132,000 | $-3,610,140 |
| Exchange Rate Effect | 150,045 | -64,000 | 134,000 | 13,000 | N/A |
| Beginning Cash Position | -399,000 | 5,050,000 | 2,509,000 | 2,355,000 | 2,045,000 |
| End Cash Position | 3,971,066 | -399,000 | 5,050,000 | 2,509,000 | -1,983,253 |
| Net Cash Flow | $-1,913,258 | $749,000 | $2,407,000 | $141,000 | $-565,756 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,621,890 | 1,719,000 | 1,424,000 | 1,192,000 | N/A |
| Capital Expenditure | -162,541 | -270,000 | -289,000 | -181,000 | -695,415 |
| Free Cash Flow | 1,459,349 | 1,449,000 | 1,135,000 | 1,011,000 | -695,415 |